|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
BR9405507A
(pt)
|
1993-07-13 |
1999-05-25 |
Rhone Poulenc Rorer Sa |
Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
|
|
US6635472B1
(en)
*
|
1997-08-15 |
2003-10-21 |
Rubicon Laboratory, Inc. |
Retrovirus and viral vectors
|
|
AU1124499A
(en)
*
|
1997-10-28 |
1999-05-17 |
Maxygen, Inc. |
Human papillomavirus vectors
|
|
AU3097399A
(en)
|
1998-03-20 |
1999-10-11 |
Trustees Of The University Of Pennsylvania, The |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
ES2323744T3
(es)
|
1998-10-01 |
2009-07-23 |
University Of Southern California |
Sistema retroviral de suministro de genes y metodos de uso.
|
|
US6156514A
(en)
*
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US6410013B1
(en)
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
|
WO2000072886A1
(en)
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
CA2408830A1
(en)
|
2000-05-12 |
2001-11-22 |
The Regents Of The University Of California |
Treatment of human papillomavirus (hpv)-infected cells
|
|
AU2001265187A1
(en)
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
US20030119770A1
(en)
|
2001-08-02 |
2003-06-26 |
Zhennan Lai |
Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
|
|
WO2003015708A2
(en)
|
2001-08-18 |
2003-02-27 |
Myriad Genetics, Inc |
Composition and method for treating hiv infection
|
|
US7737124B2
(en)
|
2001-09-13 |
2010-06-15 |
California Institute Of Technology |
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
|
|
US20070203333A1
(en)
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
JP2005521393A
(ja)
|
2002-03-20 |
2005-07-21 |
マサチューセッツ インスティテュート オブ テクノロジー |
Ｈｉｖ治療
|
|
AU2003237159A1
(en)
|
2002-04-30 |
2003-11-17 |
University Of Florida |
Treatment for phenylketonuria
|
|
US20040161412A1
(en)
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
|
AU2003265948B8
(en)
|
2002-09-06 |
2009-09-03 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
|
|
ES2334125T3
(es)
|
2002-11-04 |
2010-03-05 |
University Of Massachusetts |
Interferencia de arn especifico de alelos.
|
|
AU2003283174A1
(en)
|
2002-12-11 |
2004-06-30 |
Cytos Biotechnology Ag |
Method for protein production
|
|
EP1631669A2
(en)
|
2003-04-09 |
2006-03-08 |
Biodelivery Sciences International, Inc. |
Cochleate compositions directed against expression of proteins
|
|
US20060246520A1
(en)
|
2003-05-23 |
2006-11-02 |
Institut National De La Sante Et De La Recherche Medicale |
Gamma delta t cell-mediated therapy
|
|
WO2005005644A1
(en)
|
2003-07-11 |
2005-01-20 |
Cytos Biotechnology Ag |
Gene expression system
|
|
US20050019927A1
(en)
|
2003-07-13 |
2005-01-27 |
Markus Hildinger |
DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER
|
|
US20050138677A1
(en)
|
2003-09-16 |
2005-06-23 |
Pfister Herbert J. |
Transgenic animal model for the treatment of skin tumors
|
|
WO2005028634A2
(en)
|
2003-09-18 |
2005-03-31 |
Emory University |
Improved mva vaccines
|
|
WO2005033282A2
(en)
|
2003-10-01 |
2005-04-14 |
Pharmacia & Upjohn Company Llc |
Polyamide compositions and therapeutic methods for treatment of human papilloma virus
|
|
US20080039413A1
(en)
|
2003-10-21 |
2008-02-14 |
Morris David W |
Novel compositions and methods in cancer
|
|
WO2005081911A2
(en)
|
2004-02-25 |
2005-09-09 |
Dana-Farber Cancer Institute, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5α
|
|
US20060058255A1
(en)
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
WO2005118802A2
(en)
|
2004-06-03 |
2005-12-15 |
The Regents Of The University Of California |
Targeting pseudotyped retroviral vectors
|
|
WO2006012221A2
(en)
|
2004-06-25 |
2006-02-02 |
The Regents Of The University Of California |
Target cell-specific short interfering rna and methods of use thereof
|
|
WO2006023491A2
(en)
|
2004-08-16 |
2006-03-02 |
The Cbr Institute For Biomedical Research, Inc. |
Method of delivering rna interference and uses thereof
|
|
EP1802641B8
(en)
|
2004-10-08 |
2012-03-07 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
|
EP1647595A1
(en)
|
2004-10-15 |
2006-04-19 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Nucleic acids against viruses, in particular HIV
|
|
US20070298498A1
(en)
|
2004-11-02 |
2007-12-27 |
Stefano Colloca |
Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof
|
|
US7790446B2
(en)
|
2005-02-11 |
2010-09-07 |
Kosagen Cell Factory Oü |
Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
|
|
AU2006214278C1
(en)
|
2005-02-16 |
2012-07-19 |
Miltenyi Biotec Technology, Inc. |
Lentiviral vectors and their use
|
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
|
WO2007015122A1
(en)
|
2005-08-02 |
2007-02-08 |
Genexel, Inc. |
Therapy for alzheimer’s disease
|
|
US20070032443A1
(en)
|
2005-08-02 |
2007-02-08 |
Jaeseob Kim |
Therapy for Alzheimer's disease
|
|
US20070105835A1
(en)
|
2005-11-07 |
2007-05-10 |
Kazantsev Aleksey G |
Compositions and methods for modulating poly(ADP-ribose) polymerase activity
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
WO2007133674A2
(en)
|
2006-05-12 |
2007-11-22 |
Lentigen Corporation |
Lentiviral vector compositions, methods and applications
|
|
WO2007149476A2
(en)
|
2006-06-19 |
2007-12-27 |
Trustees Of Columbia University In The City Of New York |
Assays for non-apoptotic cell death and uses thereof
|
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
|
US8124752B2
(en)
|
2006-07-10 |
2012-02-28 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the MYC gene
|
|
EP1878440A1
(en)
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
|
KR20090034395A
(ko)
|
2006-07-26 |
2009-04-07 |
노파르티스 아게 |
운데카프레닐 피로포스페이트 합성효소의 억제제
|
|
US20080199961A1
(en)
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
|
EP2426142A3
(en)
|
2006-10-16 |
2012-06-13 |
Genelux Corporation |
Modified vaccinia virus strains for use in a diagnostic and therapeutic method
|
|
US8338101B2
(en)
|
2007-01-23 |
2012-12-25 |
Virco Bvba |
Method for designing a drug regime for HIV-infected patients
|
|
CN101679466A
(zh)
|
2007-04-12 |
2010-03-24 |
伊利诺伊大学评议会 |
对包括fpps、ggpps和dpps在内的多靶点效力提高的二膦酸盐化合物及方法
|
|
US20080293142A1
(en)
|
2007-04-19 |
2008-11-27 |
The Board Of Regents For Oklahoma State University |
Multiple shRNA Expression Vectors and Methods of Construction
|
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
|
WO2009026328A2
(en)
|
2007-08-21 |
2009-02-26 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
EP2090659A1
(en)
|
2008-02-14 |
2009-08-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Infectious particle, process for its preparation and use thereof
|
|
US8288094B2
(en)
*
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
|
GB0810209D0
(en)
|
2008-06-04 |
2008-07-09 |
Cambridge Entpr Ltd |
Pluripotency associated epigenetic factor
|
|
US8629334B2
(en)
*
|
2008-07-16 |
2014-01-14 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system for trees
|
|
WO2010022195A2
(en)
|
2008-08-20 |
2010-02-25 |
Virxsys Corporation |
Non-integrating lenti/adeno-associated virus hybrid vector system
|
|
EP2342321B1
(en)
|
2008-09-17 |
2018-04-11 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
WO2010051521A1
(en)
|
2008-10-31 |
2010-05-06 |
Lentigen Corporation |
Cell therapy product for the treatment of hiv infection
|
|
AU2009308707A1
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
|
CN102369288A
(zh)
|
2008-11-14 |
2012-03-07 |
生命技术公司 |
用于工程化细胞的组合物和方法
|
|
EP2191834A1
(en)
|
2008-11-26 |
2010-06-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions and methods for treating retrovirus infections
|
|
US20120034197A1
(en)
|
2009-04-09 |
2012-02-09 |
Stemcyte Inc. |
Hiv-resistant stem cells and uses thereof
|
|
JP5727458B2
(ja)
|
2009-04-13 |
2015-06-03 |
アプセト ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフトＡｐｃｅｔｈ Ｇｍｂｈ ＆ Ｃｏ． Ｋｇ |
改変間葉系幹細胞及びそれを使用した腫瘍の治療方法
|
|
US8728458B2
(en)
|
2009-04-30 |
2014-05-20 |
The Regents Of The University Of California |
Combination anti-HIV vectors, targeting vectors, and methods of use
|
|
EP3659435A1
(en)
|
2009-07-15 |
2020-06-03 |
Calimmune, Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
US20120027725A1
(en)
|
2009-11-30 |
2012-02-02 |
Galvin Jeffrey A |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
|
CN101805750B
(zh)
|
2009-12-29 |
2011-11-30 |
浙江大学 |
法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途
|
|
CA2790426A1
(en)
|
2010-02-18 |
2011-08-25 |
Emory University |
Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
|
|
WO2011119942A1
(en)
|
2010-03-25 |
2011-09-29 |
Vistagen Therapeutics, Inc. |
Induction of ips cells using transient episomal vectors
|
|
WO2011133687A2
(en)
|
2010-04-20 |
2011-10-27 |
President And Fellows Of Harvard College |
Methods and compositions for inhibition of beta2-adrenergic receptor degradation
|
|
HRP20182039T1
(hr)
|
2010-04-23 |
2019-02-08 |
Cold Spring Harbor Laboratory |
NOVE STRUKTURNO DIZAJNIRANE MOLEKULE shRNA
|
|
CN102946907A
(zh)
|
2010-05-28 |
2013-02-27 |
牛津生物医学（英国）有限公司 |
慢病毒载体向脑的递送
|
|
JP5805089B2
(ja)
|
2010-08-10 |
2015-11-04 |
タカラバイオ株式会社 |
細胞集団の製造方法
|
|
WO2012048303A2
(en)
|
2010-10-07 |
2012-04-12 |
Columbia University |
METHOD FOR TREATING CANCER HARBORING A p53 MUTATION
|
|
WO2012061075A2
(en)
|
2010-10-25 |
2012-05-10 |
The Regents Of The University Of California |
Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
|
|
US8865881B2
(en)
|
2011-02-22 |
2014-10-21 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (AAV) vectors
|
|
EP3318635A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
JP6348064B2
(ja)
|
2011-11-22 |
2018-06-27 |
ザ チルドレンズ ホスピタル オブ フィラデルフィア |
効率の高いトランスジーン送達のためのウイルスベクター
|
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
CA2863964C
(en)
|
2012-02-07 |
2021-10-26 |
Global Bio Therapeutics Usa, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
IN2014KN02774A
(https=)
|
2012-06-06 |
2015-05-08 |
Bionor Immuno As |
|
|
CA2879514C
(en)
|
2012-07-17 |
2020-04-14 |
Universite De Geneve |
Nucleic acids for down-regulation of gene expression
|
|
US10233495B2
(en)
|
2012-09-27 |
2019-03-19 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
|
ES2686129T3
(es)
|
2012-11-13 |
2018-10-16 |
Codiak Biosciences, Inc. |
Administración de agentes terapéuticos
|
|
WO2014089212A1
(en)
|
2012-12-05 |
2014-06-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of metabolic disorders
|
|
US9642921B2
(en)
|
2012-12-20 |
2017-05-09 |
Tocagen Inc. |
Cancer combination therapy and recombinant vectors
|
|
WO2014117050A2
(en)
|
2013-01-26 |
2014-07-31 |
Mirimus, Inc. |
Modified mirna as a scaffold for shrna
|
|
CN103184224A
(zh)
|
2013-04-03 |
2013-07-03 |
衡阳师范学院 |
一种抗艾滋病病毒感染的三联miRNA及构建方法
|
|
WO2014187881A1
(en)
|
2013-05-21 |
2014-11-27 |
Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
|
CA2954168C
(en)
|
2013-08-02 |
2023-09-19 |
The Regents Of The University Of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
WO2015042308A2
(en)
|
2013-09-18 |
2015-03-26 |
City Of Hope |
Rna-based hiv inhibitors
|
|
EA034103B1
(ru)
|
2013-10-22 |
2019-12-27 |
Транслейт Био, Инк. |
СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
|
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
|
EP2878674A1
(en)
|
2013-11-28 |
2015-06-03 |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Stable episomes based on non-integrative lentiviral vectors
|
|
GB201322091D0
(en)
|
2013-12-13 |
2014-01-29 |
Cambridge Entpr Ltd |
Modified serpins for the treatment of bleeding disorders
|
|
RU2763795C2
(ru)
|
2014-04-23 |
2022-01-11 |
Джуно Терапьютикс, Инк. |
Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
|
|
ES2744565T3
(es)
|
2014-04-25 |
2020-02-25 |
Genethon |
Tratamiento de la hiperbilirrubinemia
|
|
LT3134432T
(lt)
|
2014-04-25 |
2020-04-10 |
Bluebird Bio, Inc. |
Mnd promotorius chimerinių antigenų receptoriams
|
|
WO2016033163A1
(en)
|
2014-08-29 |
2016-03-03 |
Immunomedics, Inc. |
Identification of cancer genes by in-vivo fusion of human cancer cells and animal cells
|
|
SI3197472T1
(sl)
|
2014-09-22 |
2022-01-31 |
Tanea Medical Ab |
Rekombinantni proteini brez PHE za uporabo pri zdravljenju fenilketonurije
|
|
WO2016057980A1
(en)
|
2014-10-10 |
2016-04-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods to eliminate cancer stem cells by targeting cd47
|
|
EP3206696A4
(en)
|
2014-10-14 |
2018-08-08 |
Texas Tech University System |
Multiplexed shrnas and uses thereof
|
|
WO2016069716A1
(en)
|
2014-10-30 |
2016-05-06 |
The Scripps Research Institute |
Compositions and methods comprising tyrosyl-trna synthetases and resveratrol compounds
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
EP3307894B1
(en)
|
2015-06-10 |
2026-01-28 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods of use thereof
|
|
JP6890831B2
(ja)
|
2015-07-08 |
2021-06-18 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Ｈｉｖ予備免疫化および免疫療法
|
|
CA2994192C
(en)
|
2015-08-13 |
2020-06-16 |
Peking University |
Induced extended pluripotent stem cells, methods of making and using
|
|
CN105112370B
(zh)
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
|
WO2017068077A1
(en)
|
2015-10-20 |
2017-04-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and products for genetic engineering
|
|
US11389546B2
(en)
|
2015-12-09 |
2022-07-19 |
Modernatx, Inc. |
Heterologous UTR sequences for enhanced mRNA expression
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
DK3402483T3
(da)
|
2016-01-15 |
2024-01-02 |
American Gene Tech Int Inc |
Fremgangsmåder og sammensætninger til aktivering af gamma-delta-T-celler
|
|
US10888613B2
(en)
|
2016-02-08 |
2021-01-12 |
American Gene Technologies International Inc. |
Method of producing cells resistant to HIV infection
|
|
DK3426777T3
(da)
|
2016-03-09 |
2022-04-25 |
American Gene Tech Int Inc |
Kombinationsvektorer og fremgangsmåder til behandling af cancer
|
|
WO2017173453A1
(en)
|
2016-04-01 |
2017-10-05 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
|
US11976292B2
(en)
|
2016-06-08 |
2024-05-07 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
IL284348B2
(en)
|
2016-07-08 |
2025-06-01 |
American Gene Tech Int Inc |
Hiv pre-immunization and immunotherapy
|
|
JP7176756B2
(ja)
|
2016-07-21 |
2022-11-22 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
パーキンソン病を処置するためのウイルスベクター
|
|
KR102738752B1
(ko)
|
2016-12-30 |
2024-12-06 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
페닐케톤뇨증을 치료하기 위한 유전자 치료
|
|
WO2018129540A1
(en)
|
2017-01-09 |
2018-07-12 |
American Gene Technologies International Inc. |
Hiv immunotherapy with no pre-immunization step
|
|
AU2018219292B2
(en)
|
2017-02-08 |
2024-09-26 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
CA3057142A1
(en)
|
2017-04-03 |
2018-10-11 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
CA3064442A1
(en)
|
2017-06-16 |
2018-12-20 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
|
|
WO2019070674A2
(en)
|
2017-10-02 |
2019-04-11 |
American Gene Technologies International Inc. |
VECTORS COMPRISING PROMOTER AND ACTIVATOR COMBINATIONS FOR THE TREATMENT OF PHENYLCETONURIA
|
|
US11352646B2
(en)
|
2018-11-05 |
2022-06-07 |
American Gene Technologies International Inc. |
Vector system for expressing regulatory RNA
|
|
BR112021024124A2
(pt)
|
2019-05-31 |
2022-01-11 |
American Gene Tech Int Inc |
Expressão otimizada de fenilalanina hidroxilase
|